3 Horrendous Health-Care
Stocks This Week
Much of the U.S. was
snowed under this week.
Several health-care stocks
unfortunately had the
same experience -- with
shiv...
Prana Biotechnology (Nasdaq: PRAN)
The stock of the biotech focusing on neurological disorders
dropped nearly 27% for the ...
Why Prana was pummeled
• Summer Street analyst Bart Classen
cast doubt on prospects for PBT2 in
treating Alzheimer’s disea...
Galena BioPharma (Nasdaq: GALE)
Shares of this biotech careened more than 24% this week.
Why Galena shares tanked
• TheStreet’s Adam Feuerstein
published a damaging article on
Wednesday.
• The article reported t...
The Medicines Company (Nasdaq: MDCO)
The drugmaker’s shares fell nearly 14% this week.
Why The Medicines Company shares sank
• An FDA advisory committee
recommended against approval
for antiplatelet agent cang...
Best shot at bouncing back?
• Galena should have a
reasonable chance at
rebounding.
• Insider selling after rising
nearly ...
Find out which stock The Motley Fool’s chief
investment officer selected as the top pick for
2014 in our free report!
Upcoming SlideShare
Loading in...5
×

3 Horrendous Healthcare Stocks This Week 2-14-14

10,733
-1

Published on

This week's worst-performing healthcare stocks

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
10,733
On Slideshare
0
From Embeds
0
Number of Embeds
11
Actions
Shares
0
Downloads
5
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-affymetrix-inc-shares-dropped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • 3 Horrendous Healthcare Stocks This Week 2-14-14

    1. 1. 3 Horrendous Health-Care Stocks This Week
    2. 2. Much of the U.S. was snowed under this week. Several health-care stocks unfortunately had the same experience -- with shivering plunges in share prices. Source: Wikimedia Commons.
    3. 3. Prana Biotechnology (Nasdaq: PRAN) The stock of the biotech focusing on neurological disorders dropped nearly 27% for the week.
    4. 4. Why Prana was pummeled • Summer Street analyst Bart Classen cast doubt on prospects for PBT2 in treating Alzheimer’s disease. • Classen thinks Prana’s phase 2b results for PBT2 don’t show statistically significant improvement. • PBT2 is also in phase 2a clinical trials targeting treatment of Huntington’s disease.
    5. 5. Galena BioPharma (Nasdaq: GALE) Shares of this biotech careened more than 24% this week.
    6. 6. Why Galena shares tanked • TheStreet’s Adam Feuerstein published a damaging article on Wednesday. • The article reported that Galena was linked to a stock-promotions firm that allegedly uses questionable tactics at the same time that insiders were selling. • Galena responded to the article – but only after a huge drop in its stock price.
    7. 7. The Medicines Company (Nasdaq: MDCO) The drugmaker’s shares fell nearly 14% this week.
    8. 8. Why The Medicines Company shares sank • An FDA advisory committee recommended against approval for antiplatelet agent cangrelor. • Concerns were voiced about the design of cangrelor’s clinical study. • The FDA isn’t bound by the recommendation – and makes its decision for approval by April 30.
    9. 9. Best shot at bouncing back? • Galena should have a reasonable chance at rebounding. • Insider selling after rising nearly 250% between Nov. 1 and Jan. 16 isn’t surprising. • Galena’s pipeline holds potential for the future.
    10. 10. Find out which stock The Motley Fool’s chief investment officer selected as the top pick for 2014 in our free report!
    1. A particular slide catching your eye?

      Clipping is a handy way to collect important slides you want to go back to later.

    ×